Clinical study using preserved serum samples obtained in clinical trials of absorbed influenza vaccine (H5N1).

Clinical study using preserved serum samples obtained in clinical trials of absorbed influenza vaccine (H5N1). - FLU-PPV-AD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220048

Enrollment

350

Registered

2010-10-15

Start date

2010-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H5N1 influenza

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who participated in one of the following clinical trials of influenza vaccine: BK-PIFA/002, KIB-PIA02, BK-PIFA003, or KIB-PIA03. Subjects must also meet the following conditions: 1) Subjects who consented to this study or subjects for whom the use of their serum samples in this study has been approved by the ethics committee and representatives of the study institution. 2) Subjects whose serum samples are available.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Determination of possible pyrogenic substances.	—

Countries

Japan

Contacts

Public ContactMiwa Izutsu

CTD inc.

mizutsu@c-ctd.co.jp+81-3-6228-4835

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026